Malcolm L. Gefter

Dr. Gefter is Professor Emeritus of Biochemistry at the Massachusetts Institute of Technology. He founded Praecis Pharmaceuticals Inc. and was Chairman of the Board, CEO, President and/or Chief Scientific Officer until it was sold to GlaxoSmithKline. He founded ImmuLogic Pharmaceutical Corporation and served as its CEO and/or Chairman of the Board for 10 years. He has authored more than 200 peer reviewed scientific publications. Dr. Gefter received his B.S. in Chemistry from the University of Maryland and his Ph.D. in Molecular Biology from Albert Einstein College of Medicine.